Completed PHASE1 INTERVENTIONAL 2-arm NCT02025998

Development of Ibudilast for Alcohol Use Disorder

Development of Ibudilast as a Novel Treatment for Alcohol Dependence

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Updated 6 times since 2017 Last updated: Feb 19, 2016 Started: Dec 31, 2013 Primary completion: Jun 30, 2015 Completion: Jun 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02025998, this PHASE1 trial focuses on Alcohol Use Disorders and remains completed. Sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Dec 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
University of California, Los Angeles

Data source: University of California, Los Angeles

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States